US3523939A
(en)
|
1967-07-03 |
1970-08-11 |
Hoffmann La Roche |
5-(2,6-disubstituted phenyl)-1,4-benzodiazepines and methods for their preparation
|
CH498846A
(de)
|
1967-08-09 |
1970-11-15 |
Hoffmann La Roche |
Verfahren zur Herstellung von Benzodiazepin-Derivaten
|
US3781289A
(en)
|
1971-02-09 |
1973-12-25 |
Upjohn Co |
7-chloro-1-methyl-5-phenyl-s-triazolo (4,3-a)quinolines
|
US3709898A
(en)
|
1971-02-09 |
1973-01-09 |
Upjohn Co |
Process for the production of triazolobenzodiazepines and intermediates
|
US3681343A
(en)
|
1971-05-11 |
1972-08-01 |
Upjohn Co |
6-phenyl-s-triazolo{8 4,3-a{9 {8 1,4{9 {0 benzodiazepines
|
DE2242918A1
(de)
|
1971-09-15 |
1973-03-22 |
Upjohn Co |
Neue 4-amino-s-triazolo eckige klammer auf 4,3-a eckige klammer zu eckige klammer auf 1,4 eckige klammer zu benzodiazepine
|
US3903103A
(en)
|
1971-09-15 |
1975-09-02 |
Upjohn Co |
4-Amino-s-triazolo-{8 4,3-a{9 {8 1,4{9 benzodiazepine
|
US3886141A
(en)
|
1971-10-07 |
1975-05-27 |
Hoffmann La Roche |
Preparation of 5-pyridyl benzodiazepine utilizing hexamethylenetetramine
|
BE795790A
(fr)
|
1972-02-22 |
1973-08-22 |
Upjohn Co |
Dibenzo-triazolo-azepine
|
US4155904A
(en)
|
1973-02-08 |
1979-05-22 |
Schering Corporation |
Process for the preparation of 1,4-benzo-diazepines and 1,4-benzodiazepinones
|
IE38931B1
(en)
|
1973-03-09 |
1978-07-05 |
Lipha |
Triazolobenzodiazepines
|
FR2220257A1
(en)
|
1973-03-09 |
1974-10-04 |
Lipha |
5,6-Dihydro-(4H)-s-triazolo-(4,3-a) (1,5)benzodiazepines - as antiinflam-matory and analgesic agents without tranquillising effects
|
US3966736A
(en)
|
1975-04-07 |
1976-06-29 |
The Upjohn Company |
2,9-Dihydro-3H-pyrido[3,2-c]-s-triazolo[4,3-a][1,5]-benzodiazepin-3-ones
|
AT350056B
(de)
|
1975-11-04 |
1979-05-10 |
Degussa |
Verfahren zur herstellung von neuen pyrido- (2,3-f)-(1,4)-diazepinen, deren optischen isomeren und salzen
|
DE2640599A1
(de)
|
1976-09-09 |
1978-03-16 |
Scherico Ltd |
Verfahren zur herstellung von 1,4- benzodiazepinen
|
CA1152066A
(en)
|
1980-02-08 |
1983-08-16 |
Hoffmann-La Roche Limited |
Benzodiazepine derivatives
|
CA1157855A
(en)
|
1980-07-31 |
1983-11-29 |
Albert E. Fischli |
Benzodiazepine derivatives
|
CA1163266A
(en)
|
1980-07-31 |
1984-03-06 |
Albert E. Fischli |
Benzodiazepine derivatives
|
US4455307A
(en)
|
1982-01-04 |
1984-06-19 |
The Upjohn Company |
Antihypertensive use of triazolobenzodiazepines
|
US4663321A
(en)
|
1984-06-26 |
1987-05-05 |
Merck & Co., Inc. |
Triazolobenzodiazepines and pharmaceutical use
|
US4820834A
(en)
|
1984-06-26 |
1989-04-11 |
Merck & Co., Inc. |
Benzodiazepine analogs
|
US5004741A
(en)
|
1984-06-26 |
1991-04-02 |
Merck & Co., Inc. |
Methods of antagonizing CCK or gastrin with benzodiazepine analogs
|
EP0315698B1
(en)
|
1987-05-28 |
1993-03-03 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thieno(triazolo)diazepine compounds and medicinal application of the same
|
MC1999A1
(fr)
|
1987-12-18 |
1990-01-26 |
Hoffmann La Roche |
Composes tricycliques
|
US4959361A
(en)
|
1987-12-18 |
1990-09-25 |
Hoffmann-La Roche Inc. |
Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists
|
US4992437A
(en)
|
1987-12-22 |
1991-02-12 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienodiazepine compounds and their pharmaceutical use
|
CA1324863C
(en)
|
1988-01-30 |
1993-11-30 |
Minoru Moriwaki |
Thienotriazolodiazepine compounds and pharmaceutical uses thereof
|
CA1322367C
(en)
|
1988-05-17 |
1993-09-21 |
Yoshitomi Pharmaceutical Industries Ltd. |
Thienotriazolodiazepine compounds and pharmaceutical uses thereof
|
FI95708C
(fi)
|
1988-10-31 |
1996-03-11 |
Eisai Co Ltd |
Analogiamenetelmä 1,4-diatsepiinijohdannaisen ja sen farmaseuttisesti sopivan suolan valmistamiseksi
|
US5221671A
(en)
|
1988-10-31 |
1993-06-22 |
Eisai Co., Ltd. |
Triazolo-1,4-diazepine derivatives and their use in pharmaceuticals
|
US5382579A
(en)
|
1988-10-31 |
1995-01-17 |
Eisai Co., Ltd. |
Triazolo-1,4-diazepine derivatives and their use in pharmaceuticals
|
DE3936828A1
(de)
|
1988-11-06 |
1990-05-10 |
Boehringer Ingelheim Kg |
Neue hetrazepine
|
DE4006471A1
(de)
|
1989-03-03 |
1990-09-06 |
Boehringer Ingelheim Kg |
Neue thienodiazepine
|
YU133090A
(sh)
|
1989-07-12 |
1993-10-20 |
Boehringer Ingelheim Kg. |
Novi heteroazepini s paf-antaganostičnim učinkom in postopek za njihovo pripravo
|
DE69017302T3
(de)
|
1989-08-04 |
1999-08-05 |
Merck Sharp & Dohme Ltd., Hoddesdon, Hertfordshire |
Zentrale Cholecystokinin-Antagonisten zur Behandlung von psychiatrischen Krankheiten.
|
US5175159A
(en)
|
1989-10-05 |
1992-12-29 |
Merck & Co., Inc. |
3-substituted-1,4-benzodiazepines as oxytocin antagonists
|
CA2032427A1
(en)
|
1989-12-18 |
1991-06-19 |
Mark G. Bock |
Benzodiazepines analogs
|
IL96613A0
(en)
|
1989-12-18 |
1991-09-16 |
Merck & Co Inc |
Pharmaceutical compositions containing benzodiazepine analogs
|
JP2971901B2
(ja)
|
1990-03-15 |
1999-11-08 |
エーザイ株式会社 |
トリアゾロ―1,4―ジアゼピン系化合物
|
JP2971902B2
(ja)
|
1990-03-15 |
1999-11-08 |
エーザイ株式会社 |
トリアゾロ―1,4―ジアゼピン系化合物
|
WO1994006801A1
(en)
|
1990-05-23 |
1994-03-31 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienodiazepine compound and medicinal use thereof
|
JP2959591B2
(ja)
|
1990-05-23 |
1999-10-06 |
吉富製薬株式会社 |
チエノトリアゾロジアゼピン化合物
|
DE4027470A1
(de)
|
1990-08-30 |
1992-03-05 |
Boehringer Ingelheim Kg |
Neue hetrazepinoide amide
|
JP2959598B2
(ja)
|
1990-10-12 |
1999-10-06 |
吉富製薬株式会社 |
光学活性なチエノトリアゾロジアゼピン化合物
|
US5206234A
(en)
|
1990-10-22 |
1993-04-27 |
Merck & Co., Inc. |
Benzolactam analogs as antagonists of cck
|
CA2056809A1
(en)
|
1990-12-07 |
1992-06-08 |
Mark G. Bock |
Benzodiazepine analogs
|
DE4101146A1
(de)
|
1991-01-16 |
1992-07-23 |
Boehringer Ingelheim Kg |
Neue in 6-position substituierte diazepine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
DE4107521A1
(de)
|
1991-03-08 |
1992-09-10 |
Boehringer Ingelheim Kg |
Neue acylaminosubstituierte hetrazepine
|
US5683998A
(en)
|
1991-04-23 |
1997-11-04 |
Toray Industries, Inc. |
Tricyclic triazolo derivatives, processes for producing the same and the uses of the same
|
US5185331A
(en)
|
1991-05-14 |
1993-02-09 |
Merck & Co., Inc. |
Triazolobenzodiazepines
|
CA2071092A1
(en)
|
1991-06-14 |
1992-12-15 |
Roger M. Freidinger |
1,4-benzodiazepines with 5-membered heterocyclic rings
|
GB9117852D0
(en)
|
1991-08-19 |
1991-10-09 |
Merck Sharp & Dohme |
Therapeutic agents
|
US5153191A
(en)
|
1991-08-20 |
1992-10-06 |
Warner-Lambert Company |
Cholecystokinin antagonists useful for treating depression
|
DE4128581A1
(de)
|
1991-08-28 |
1993-03-04 |
Boehringer Ingelheim Kg |
Verwendung von paf-antagonisten hetrazepinoider struktur zur behandlung der allergischen rhinitis
|
ES2140396T3
(es)
|
1991-09-30 |
2000-03-01 |
Yoshitomi Pharmaceutical |
Compuesto de tienodiazepina y su uso.
|
EP0638560A4
(en)
|
1991-10-11 |
1995-03-29 |
Yoshitomi Pharmaceutical |
MEDICINE FOR OSTEOPOROSIS AND DIAZEPINE COMPOUND *.
|
ES2143993T3
(es)
|
1991-12-11 |
2000-06-01 |
Yoshitomi Pharmaceutical |
Farmaco para tratar una enfermedad autoinmune.
|
JPH07507993A
(ja)
|
1991-12-20 |
1995-09-07 |
メルク シヤープ エンド ドーム リミテツド |
医薬活性を有する中枢神経系コレシストキニンアンタゴニスト
|
DE4200610A1
(de)
|
1992-01-13 |
1993-07-15 |
Boehringer Ingelheim Kg |
Verwendung von paf-antagonisten zur behandlung der dysmenorrhea
|
AU670431B2
(en)
|
1992-03-24 |
1996-07-18 |
Merck Sharp & Dohme Limited |
3-ureido substituted benzodiazepin-2-ones having cholecystokinin and/or gastrin antagonistic activity and their use in therapy
|
DE4219659A1
(de)
|
1992-06-16 |
1993-12-23 |
Boehringer Ingelheim Kg |
Die Verwendung von PAF-Antagonisten in Kombination mit Anticholinergika
|
WO1994006802A1
(en)
|
1992-09-18 |
1994-03-31 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienodiazepine compound and medicinal use thereof
|
JP3223290B2
(ja)
|
1992-11-10 |
2001-10-29 |
日本電信電話株式会社 |
マイクロ回転体およびその製造方法
|
US5302590A
(en)
|
1992-12-18 |
1994-04-12 |
Hoffmann-La Roche Inc. |
Compounds useful as dual antagonists of platelet activating factor and leukotriene D4
|
CA2159344A1
(en)
|
1993-03-30 |
1994-10-13 |
Minoru Moriwaki |
Cell adhesion inhibitor and thienotriazolodiazepine compound
|
EP0698015A1
(en)
|
1993-05-14 |
1996-02-28 |
Genentech, Inc. |
Preparation of n-cyanodithioimino-carbonates and 3-mercapto-5-amino-1h-1,2,4-triazole
|
US5869483A
(en)
|
1993-07-29 |
1999-02-09 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
US5733905A
(en)
|
1993-07-29 |
1998-03-31 |
American Cyanamid Company |
Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
|
US5516774A
(en)
|
1993-07-29 |
1996-05-14 |
American Cyanamid Company |
Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
|
US5760031A
(en)
|
1993-07-29 |
1998-06-02 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
JP3633008B2
(ja)
|
1993-11-15 |
2005-03-30 |
三菱ウェルファーマ株式会社 |
チエノトリアゾロジアゼピン化合物
|
JP2840454B2
(ja)
|
1993-11-22 |
1998-12-24 |
メルク エンド カンパニー インコーポレーテッド |
ベンゾジアゼピン類
|
ES2156933T3
(es)
|
1993-12-28 |
2001-08-01 |
Meiji Seika Co |
Derivados triciclicos de benzazepina y benzotiazepina.
|
US5739129A
(en)
|
1994-04-14 |
1998-04-14 |
Glaxo Wellcome Inc. |
CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
|
AU2446295A
(en)
|
1994-04-15 |
1995-11-10 |
Glaxo Inc. |
A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds
|
JP3264588B2
(ja)
|
1994-08-23 |
2002-03-11 |
松下電器産業株式会社 |
電子地図データの生成装置
|
JP3264589B2
(ja)
|
1994-09-07 |
2002-03-11 |
東芝機械株式会社 |
研磨装置
|
DK0906907T3
(da)
|
1995-09-21 |
2002-04-22 |
Inst Med Molecular Design Inc |
Forbindelser, der potenserer retinoid
|
BR9710453A
(pt)
|
1996-06-12 |
1999-08-17 |
Japan Tobacco Inc |
Inhibidor de produ-Æo de citocina composto de triazepina e intermedi rio para o mesmo
|
AU716490B2
(en)
|
1996-09-13 |
2000-02-24 |
Mitsubishi Tanabe Pharma Corporation |
Thienotriazolodiazepine compounds and pharmaceutical use thereof
|
NZ335583A
(en)
|
1996-12-23 |
2001-03-30 |
Lilly Co Eli |
Cycloalkyl, lactam, lactone and analogs, and pharmaceutical compositions
|
US6433167B1
(en)
|
1997-06-25 |
2002-08-13 |
Nikken Chemicals Co., Ltd. |
Triazolo-1,4-diazepine compounds and medicinal composition containing the same
|
JP4204657B2
(ja)
|
1997-12-05 |
2009-01-07 |
有限会社ケムフィズ |
糖尿病の予防・治療剤
|
JPH11228576A
(ja)
|
1997-12-10 |
1999-08-24 |
Japan Tobacco Inc |
アポトーシス抑制剤
|
FR2779652B1
(fr)
|
1998-06-15 |
2001-06-08 |
Sod Conseils Rech Applic |
Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique
|
PE20000944A1
(es)
|
1998-07-31 |
2000-09-20 |
Lilly Co Eli |
Derivados de sulfonamida
|
EP1107983A2
(en)
|
1998-09-01 |
2001-06-20 |
Innogenetics N.V. |
Benzodiazepine and benzothiazepine derivatives and hbsag peptides binding to annexins, their compositions and use
|
WO2000054778A1
(fr)
|
1999-03-12 |
2000-09-21 |
Welfide Corporation |
Agents preventifs ou therapeutiques des dermatoses inflammatoires
|
FR2791980B1
(fr)
|
1999-04-09 |
2001-07-06 |
Sod Conseils Rech Applic |
Pyrido-thieno-diazepines, leur procede de preparation, et les compositions pharmaceutiques les contenant
|
US7160880B1
(en)
|
1999-05-14 |
2007-01-09 |
Cenes Limited |
Short-acting benzodiazepines
|
GB9911152D0
(en)
|
1999-05-14 |
1999-07-14 |
Glaxo Group Ltd |
Short-acting benzodiazepines
|
AU2733301A
(en)
|
1999-12-29 |
2001-07-09 |
Glaxo Group Limited |
Methods and compositions related to modulators of annexin and cartilage homeostasis
|
EP1297836A4
(en)
|
2000-06-16 |
2007-06-13 |
Mitsubishi Pharma Corp |
COMPOSITIONS FOR CHECKING RELEASE, PH AREA AND / OR SPEED
|
EP1392663A2
(fr)
|
2001-06-07 |
2004-03-03 |
Neuro3D |
Inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations de ces inhibiteurs
|
US20050096322A1
(en)
|
2002-03-01 |
2005-05-05 |
Susumu Igarashi |
Nitrogen-containing heterocyclic compound
|
EP1556055B1
(fr)
|
2002-10-30 |
2008-10-29 |
Via Pharmaceuticals, Inc. |
Inhibiteurs des phosphodiesterases des nucleotides cycliques, ayant une structure benzodiazepinique, et leur utilisation en therapie
|
DE10251927A1
(de)
|
2002-11-08 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
US7482337B2
(en)
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
KR100562489B1
(ko)
|
2002-11-11 |
2006-03-21 |
삼성전자주식회사 |
셔터 타이밍 조절 가능한 로우 디코더를 갖는 이미지 센서
|
WO2004058769A2
(en)
|
2002-12-18 |
2004-07-15 |
Vertex Pharmaceuticals Incorporated |
Triazolopyridazines as protein kinases inhibitors
|
US20060173009A1
(en)
|
2003-01-07 |
2006-08-03 |
Hiroyuki Kanoh |
Agent inducing increase in bone mass
|
US7119088B2
(en)
|
2003-02-19 |
2006-10-10 |
Pfizer Inc. |
Triazole compounds useful in therapy
|
WO2005099759A1
(ja)
|
2004-04-16 |
2005-10-27 |
Institute Of Medicinal Molecular Design. Inc. |
動脈硬化症の予防及び/又は治療のための医薬
|
KR20070103352A
(ko)
|
2004-10-05 |
2007-10-23 |
파이오니아 가부시키가이샤 |
오디오 랙
|
WO2006129623A1
(ja)
|
2005-05-30 |
2006-12-07 |
Mitsubishi Tanabe Pharma Corporation |
チエノトリアゾロジアゼピン化合物及びその医薬としての用途
|
WO2007016087A2
(en)
|
2005-07-29 |
2007-02-08 |
Merck & Co., Inc. |
Heterocyclic benzodiazepine cgrp receptor antagonists
|
US20070105844A1
(en)
|
2005-10-26 |
2007-05-10 |
Regents Of The University Of Michigan |
Therapeutic compositions and methods
|
JP2009513644A
(ja)
|
2005-10-26 |
2009-04-02 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
治療組成物および方法
|
DE102005061840A1
(de)
|
2005-12-23 |
2007-06-28 |
Merck Patent Gmbh |
Triazolderivate
|
JPWO2008023847A1
(ja)
|
2006-08-25 |
2010-01-14 |
日本ケミファ株式会社 |
P2x4受容体拮抗剤
|
WO2008109856A2
(en)
|
2007-03-07 |
2008-09-12 |
Xenon Pharmaceuticals Inc. |
Methods of using diazepinone compounds in treating sodium channel-mediated diseases or conditions
|
US20090111780A1
(en)
|
2007-10-31 |
2009-04-30 |
Everett Laboratories, Inc. |
Compositions and methods for treatment of ear canal infection and inflammation
|
ITFI20070288A1
(it)
|
2007-12-21 |
2009-06-22 |
A I L Firenze Sezione Autonoma |
Inibitori delle deacetilasi istoniche
|
KR101600634B1
(ko)
|
2007-12-28 |
2016-03-07 |
미쓰비시 타나베 파마 코퍼레이션 |
항암제
|
WO2009152589A1
(en)
|
2008-06-17 |
2009-12-23 |
Universidade Federal De Minas Gerais-Ufmg |
Use of paf receptor for treating infections caused by flaviviridae
|
JP5634990B2
(ja)
|
2008-06-23 |
2014-12-03 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
タンパク質キナーゼ阻害剤
|
BRPI0914406A2
(pt)
|
2008-10-30 |
2015-10-20 |
Circomed Llc |
composto, composição farmacêutica, e, método para aumentar os níveis no plasma de apo a1 em um mamífero
|
WO2010118207A1
(en)
|
2009-04-09 |
2010-10-14 |
Schering Corporation |
Pyrazolo [1, 5-a] pyrimidine derivatives as mtor inhibitors
|
US8604023B2
(en)
|
2009-04-17 |
2013-12-10 |
The Regents Of The University Of Michigan |
1,4-benzodiazepinone compounds and their use in treating cancer
|
JP5768239B2
(ja)
|
2009-05-07 |
2015-08-26 |
株式会社 PRISM BioLab |
アルファへリックスミメティック及び関連の方法
|
JP5442021B2
(ja)
|
2009-09-28 |
2014-03-12 |
日本曹達株式会社 |
含窒素ヘテロ環化合物およびその塩ならびに農園芸用殺菌剤
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
SI2496580T1
(sl)
|
2009-11-05 |
2014-02-28 |
Glaxosmithkline Llc |
Benzodiazepinski inhibitorji bromodomene
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
ES2539964T3
(es)
|
2009-11-05 |
2015-07-07 |
Glaxosmithkline Llc |
Procedimiento novedoso
|
GB0919426D0
(en)
*
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
PL2496582T3
(pl)
|
2009-11-05 |
2016-08-31 |
Glaxosmithkline Llc |
Benzodiazepinowy inhibitor bromodomeny
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
US8765920B2
(en)
|
2009-12-23 |
2014-07-01 |
The Scripps Research Institute |
Tyrosine bioconjugation through aqueous Ene-like reactions
|
WO2011123678A2
(en)
|
2010-03-31 |
2011-10-06 |
Arqule, Inc. |
Substituted benzo-pyrido-triazolo-diazepine compounds
|
BR112012029057A2
(pt)
|
2010-05-14 |
2020-10-13 |
Dana-Farber Cancer Institute, Inc. |
composições e métodos de tratamento de leucemia
|
US9301962B2
(en)
|
2010-05-14 |
2016-04-05 |
Baylor College Of Medicine |
Male contraceptive compositions and methods of use
|
US8981083B2
(en)
|
2010-05-14 |
2015-03-17 |
Dana Farber Cancer Institute, Inc. |
Compositions and methods for treating neoplasia, inflammatory disease and other disorders
|
US20130252331A1
(en)
|
2010-05-14 |
2013-09-26 |
James Elliott Bradner |
Compositions and methods for modulating metabolism
|
WO2011161031A1
(en)
*
|
2010-06-22 |
2011-12-29 |
Glaxosmithkline Llc |
Benzotriazolodiazepine compounds inhibitors of bromodomains
|
AR084070A1
(es)
*
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
WO2012075456A1
(en)
|
2010-12-02 |
2012-06-07 |
Constellation Pharmaceuticals |
Bromodomain inhibitors and uses thereof
|
WO2012151512A2
(en)
|
2011-05-04 |
2012-11-08 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
GB201114103D0
(en)
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
WO2013033270A2
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bromodomain ligands capable of dimerizing in an aqueous solution, and methods of using same
|
WO2013033269A1
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
|
WO2013033420A1
(en)
|
2011-08-30 |
2013-03-07 |
Whitehead Institute For Biomedical Research |
Methods of downregulating translocated oncogene expression using bromodomain inhibitors
|
DE102011082013A1
(de)
|
2011-09-01 |
2013-03-07 |
Bayer Pharma AG |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
|
EP2864336B1
(en)
|
2012-06-06 |
2016-11-23 |
Constellation Pharmaceuticals, Inc. |
Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
|
TWI602820B
(zh)
|
2012-06-06 |
2017-10-21 |
星宿藥物公司 |
溴域抑制劑及其用途
|